Home / Market News / $SGRY

$SGRY news and market catalysts

The 13 most recent market catalysts affecting $SGRY, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

13 catalysts 5 high impact 2 bullish 8 bearish Healthcare Services
Nov 11, 2026 Corporate Catalyst Bearish Impact 65
Mizuho Securities Downgrades Surgery Partners to Neutral
Mizuho Securities downgraded Surgery Partners (SGRY) to Neutral from Outperform, setting a $25 price target. This action follows the company's recent third-quarter financial report…
Nov 9, 2026 Corporate Catalyst Bearish Impact 95
Surgery Partners Rejects $28 Per Share Bid from UnitedHealth Group
Surgery Partners rejected a $28 per share acquisition bid from UnitedHealth Group, citing significant regulatory risks and potential delays. This decision is a major corporate cata…
Nov 2, 2026 Corporate Catalyst Bearish Impact 75
TD Cowen Downgrades Surgery Partners to Hold
TD Cowen downgraded Surgery Partners (SGRY) to 'Hold' from 'Buy' after the company announced its pending acquisition by HealthSpan Partners. The new price target of $23.50 aligns w…
Oct 28, 2026 Corporate Catalyst Bearish Impact 65
UBS Downgrades Surgery Partners to Neutral
UBS downgraded Surgery Partners (SGRY) from Buy to Neutral and set a new price target of $23.50. This action is significant because it directly references a 'recently announced acq…
Oct 26, 2026 Corporate Catalyst Neutral Impact 95
Bon Secours Mercy Health Reportedly Nears $6 Billion Acquisition of Surgery Partners
Bon Secours Mercy Health is reportedly close to acquiring Surgery Partners for an estimated $6 billion. This potential transaction represents a major consolidation event within the…
Aug 11, 2026 Corporate Catalyst Bullish Impact 55
TD Cowen Maintains Buy on Surgery Partners, Raises Price Target to $19
TD Cowen analyst Ryan Langston maintained a 'Buy' rating on Surgery Partners (SGRY) and raised the price target from $17 to $19. This action signals increased confidence from the a…
Aug 11, 2026 Corporate Catalyst Bearish Impact 55
RBC Capital Maintains Outperform on Surgery Partners, Lowers Price Target to $19
RBC Capital's analyst Ben Hendrix maintained an 'Outperform' rating on Surgery Partners (SGRY), signaling continued confidence in the company's long-term prospects. However, the pr…
Aug 11, 2026 Corporate Catalyst Neutral Impact 55
Cantor Fitzgerald Reiterates Overweight on Surgery Partners, Maintains $18 Price Target
Cantor Fitzgerald analyst Sarah James has reaffirmed her 'Overweight' rating and $18 price target for Surgery Partners (SGRY). This action signals that the analyst's positive outlo…
Aug 10, 2026 Corporate Catalyst Bearish Impact 92
Surgery Partners Q2 Adj. EPS $0.10 Beats $0.06 Estimate, Sales $848.900M Beat $830.366M Estimate
Surgery Partners (SGRY) announced Q2 adjusted EPS of $0.10, significantly beating the $0.06 consensus estimate, and sales of $848.9 million, also surpassing the $830.366 million es…
Aug 10, 2026 Corporate Catalyst Bearish Impact 55
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est
Surgery Partners (SGRY) filed an 8-K to affirm its fiscal year 2026 sales outlook, maintaining the range of $3.350 billion to $3.450 billion. This is significant because it indicat…
Jul 24, 2026 Corporate Catalyst Bullish Impact 85
Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth
Surgery Partners (SGRY) announced the sale of its Idaho Falls facilities for $795 million, a substantial divestiture representing the largest step in its portfolio optimization str…
Jul 24, 2026 Corporate Catalyst Bearish Impact 55
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est
Surgery Partners (SGRY) filed an 8-K to affirm its fiscal year 2026 sales outlook, maintaining the range of $3.350 billion to $3.450 billion. This is significant because it directl…
Jul 24, 2026 Corporate Catalyst Neutral Impact 85
Surgery Partners To Sell Ownership Interests In Mountain View Hospital And Idaho Falls Community Hospital To Intermountain Health; Deal Values Combined Idaho Falls Facilities At ~$1.15B, Total Consideration To Surgery Partners ~$795M
Surgery Partners (SGRY) is selling its ownership interests in two Idaho hospitals to Intermountain Health for an estimated $795 million. This is a significant corporate action as i…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.